CRT 2025
Review the Guidelines Session
Sunil V. Rao, MD, FSCAI
Professor of Medicine
NYU Langone Health System
New York, New York, United States
Disclosure(s): No financial relationships to disclose
Subhash Banerjee, MD
Chief of Cardiovascular Research & Innovation
Baylor Scott & White Heart and Vascular Institute, Dallas, TX
Dallas, Texas, United States
Disclosure(s): AngioSafe: Consulting Fees (e.g., advisory boards) (Ongoing); Espirion: Grant/Research Support (Ongoing); GE Healthcare Bio-Sciences: Grant/Research Support (Ongoing); Kaneka: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Novartis: Grant/Research Support (Ongoing)
Issam Moussa, MD
Medical Director, Carle Heart & Vascular Institte
Carle Health / University of Illinois Urbana Champaign
Dallas, Texas, United States
Disclosure(s): No financial relationships to disclose
Tanveer Rab, MD, FACC, MSCAI
Professor
Emory University
Decatur, Georgia, United States
Disclosure(s): No financial relationships to disclose
Gregg W. Stone, MD, FACC, MSCAI
Physician
Mount Sinai
New York, New York, United States
Disclosure(s): Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Vascular Dynamics, Pulnovo, V-wave: Research support to Mount Sinai Hospital (Ongoing); Apollo Therapeutics, Cardiac Success, Occlutech, Millennia Biopharma, RCE, Ablative Solutions, Abbott: Consultant (Terminated); Boehringer Ingelheim: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave, Biosense-Webster, Bioventrix: Research support to Mount Sinai Hospital (Terminated); Valfix, Zoll, HeartFlow, Shockwave, Ancora, Impulse Dynamics, Adona Medical, Oxitope, HighLife, Elixir, Elucid Bio, Aria, Alleviant, FBR Medical: Consultant (Ongoing)